We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.

News and Events

Find our current Cardiothoracic events and news stories below.

Patient Peter Ciaccia's Story

Leonard Girardi, Cardiac surgery, cardiac surgeon, aortic aneurysm,
Peter Ciaccia had a 6 cm bulge in his ascending aortic. Dr. Leonard Girardi made an incision in his chest and repaired the aortic aneurysm by replacing the aortic valve using a natural valve made from cow heart tissue. 
Peter, was the former President of Events for New York Road Runners and Race Director of the New York City Marathon for 18 years is dedicated to fitness and a long-time distance runner. 

NYP and Weill Cornell Cardiothoracic Surgery was voted #1 in Healthgrades

NYP and Weill Cornell Cardiothoracic Surgery was voted #1 out of 50 hospitals in the US in superior clinical outcomes in Heart Bypass Surgery and Heart Valve Surgery. Click here for more details.

NYP and Weill Cornell Cardiothoracic Surgery #1, Heart Bypass Surgery, Heart Valve Surgery, mortality, complications

COVID-19 Related Airway Complications Customization of Airway Stents and the Role of 3-D Printing

COVID-19 related airway complications customization of airway stents and the roles of 3-d printing

Tracheobronchomalacia (TBM): Overview of Diagnostic and Therapeutic Approaches

tracheobronchomalacia, TBM, Dr. Eugene Shostak, Dr. Oliver Chow,

The Push–Pull of Industry in Interventional Cardiovascular Trials

Patrice Wendling

June 03, 2020

One in five trials (16.2%) were not prospectively registered before the start of enrollment, and at least one major discrepancy existed between the registered and published primary outcome in 38% of registered trials.

Click here to learn more about the article

Type of Sponsorship Associated with Differences Between Trials for Invasive Cardiovascular Treatments

Mario Gaudino, ROMA Trial, CABG, Invasive Cardiovascular Treatments, cardiovascular diseaseIn randomized clinical trials, commercial sponsorship influences how studies are designed and the results reported in ways that often benefit the study’s sponsor, Weill Cornell Medicine and NewYork-Presbyterian investigators report in a new study. The findings underscore the need to improve study design, reporting and guidelines to avoid bias in these trials, the authors say.

The study, published June 1 in JAMA Internal Medicine, focuses on coronary, vascular and structural interventional cardiology, and vascular and cardiac surgeries because of the enormous burden cardiovascular disease places on public health. In the United States, it accounts for approximately 800,000 deaths per year and 6 percent of total dollars spent on healthcare. A rigorous approach to evaluating new interventions for heart disease is critical.

“In medicine in general, but in particular cardiovascular medicine, we see randomized clinical trials as the best form of evidence,” said lead author Dr. Mario Gaudino, a professor in cardiothoracic surgery and director of translational and clinical research in cardiothoracic surgery at Weill Cornell Medicine, and a cardiovascular surgeon at NewYork-Presbyterian/Weill Cornell Medical Center. “Our practice is very heavily influenced by the results of randomized clinical trials. If those trials are not properly performed and reported, there’s a risk that we use the wrong strategy and don’t treat patients in the best possible way.”

Click here to learn more about this article

Recent invasive CV trials fall short on certain design aspects

Contemporary randomized clinical trials assessing invasive CV interventions are often small with short follow-up and limited power to identify large treatment effects, according to a study published in JAMA Internal Medicine.

The study also found that commercially supported trials were linked to differences in results, design and reporting. In particular, commercially supported trials were more likely to report favorable outcomes than other trials, and to report findings inconsistent with the trial results.

In this cross-sectional study, Mario F.L. Gaudino, MD, FEBCTS, Stephen and Suzanne Weiss Professor of Cardiothoracic Surgery at Weill Cornell Medicine, and colleagues analyzed data from 216 randomized clinical trials focused on vascular, coronary and structural interventional cardiology and vascular and cardiac surgeries.

Click here to learn more about the article

Free Event: Smoking and COVID-19: Expert Panel and Q&A

On #WorldNoTobaccoDay, Dr. @BrendonStilesMD of @WCM_CTSurgery & @nyphospital will discuss how #COVID19 affects the lungs/heart if you smoke/vape.

Brendon Stiles, Lung health, Heart, Covid-19, smoking, vaping, Tobacco Use

Population Health Sciences Grand Roounds - 05/20/20

Mario Gaudino, ROMA Trial

Kids Health Cast - Teen Vaping and the Impact of Vaping on Public Health

teen vaping, Brendon Stiles, Thoracic Surgery, instead of vaping, kids health cast

In this episode #InsteadofVaping, Brendon Stiles, MD and Jonathan Avery, MD examine the dangers of teen vaping. They share great advice on preventing kids from vaping or getting your kids to quit if they have started. #wcmctsurgery

Click here to find out more about the podcast

Weill Cornell Medicine Cardiothoracic Surgery 525 East 68th Street
Box 110
Suite M 404
New York, NY 10065 Directions
Phone: (212) 746-5166

Explore